ConductScience.org, home

Paper · 214511

In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.

Slaughter L and 4 others. J Exp Med, 1978. Cited by 260 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. Papers, record 214511. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/214511

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.
PubMed
Journal
J Exp Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
260
iCite
Relative citation ratio, by iCite
7.69
iCite
Revised in PubMed
2019-05-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Slaughter LL
2Carson DAD A
3Jensen FCF C
4Holbrook TLT L
5Vaughan JHJ H

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Herpesvirus 4, HumanMajor topic
LymphocytesMajor topic
Antibodies, Anti-Idiotypic
Antibody Specificity
Humans
Immunoglobulin M
Lymphocyte Activation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1198,662Lymphoma, immunodeficiency and the Epstein-Barr virus.N Engl J Med1977https://conductscience.org/library/papers/198662PubMed
2198,660Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.N Engl J Med1977https://conductscience.org/library/papers/198660PubMed
3198,668Induction of plaque-forming cells in cultured human lymphocytes by combined action of antigen and EB virus.Nature1977https://conductscience.org/library/papers/198668PubMed
4195,004Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.J Exp Med1977https://conductscience.org/library/papers/195004PubMed
5189,490Efficiency of transformation of lymphocytes by Epstein-Barr virus.Virology1977https://conductscience.org/library/papers/189490PubMed
64,346,033Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4346033PubMed
74,631,402Studies on monoclonal antibodies. I. The specificity and binding properties of a Waldenström macroglobulin with anti- G activity.J Lab Clin Med1973https://conductscience.org/library/papers/4631402PubMed
84,328,798Detection of Epstein-Barr viral genome in nonproductive cells.Nat New Biol1971https://conductscience.org/library/papers/4328798PubMed
94,158,937Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis.N Engl J Med1966https://conductscience.org/library/papers/4158937PubMed
104,364,259Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.Int J Cancer1973https://conductscience.org/library/papers/4364259PubMed

Cited by75

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.

PMIDTitleJournalYearIn PapersSource
40,094,988Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis.J Clin Med2025https://conductscience.org/library/papers/40094988PubMed
39,982,406Rheumatoid factors revisited in the age of biologic therapy.Rheumatology (Oxford)2025https://conductscience.org/library/papers/39982406PubMed
39,092,366Anti-carbamylated Protein Antibodies Positivity in Rheumatoid Arthritis and Its Association With Rheumatoid Factor and Anti-cyclic Citrullinated Protein Antibodies.Cureus2024https://conductscience.org/library/papers/39092366PubMed
37,133,700Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.Clin Oral Investig2023https://conductscience.org/library/papers/37133700PubMed
36,510,582Correlation of rheumatoid and cardiac biomarkers with cardiac anatomy and function in rheumatoid arthritis patients without clinically overt cardiovascular diseases: A cross-sectional study.Int J Cardiol Heart Vasc2023https://conductscience.org/library/papers/36510582PubMed
36,467,904Rethink About the Role of Rheumatoid Factor and Anti-citrullinated Protein Antibody in Rheumatoid Arthritis.Rheumatol Immunol Res2021https://conductscience.org/library/papers/36467904PubMed
33,546,243Rheumatoid Factor: A Novel Determiner in Cancer History.Cancers (Basel)2021https://conductscience.org/library/papers/33546243PubMed
33,445,768From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.Int J Mol Sci2021https://conductscience.org/library/papers/33445768PubMed
24,324,289Rheumatoid factors: clinical applications.Dis Markers2013https://conductscience.org/library/papers/24324289PubMed
24,183,354EBV-encoded small RNA1 and nonresolving inflammation in rheumatoid arthritis.Kaohsiung J Med Sci2013https://conductscience.org/library/papers/24183354PubMed

1 to 10 of 75

See all 75 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/214511

GET https://conductscience.org/api/papers/v1/214511/cited_by?page=2